Filter Results:
(6,517)
Show Results For
- All HBS Web
(6,517)
- People (18)
- News (2,152)
- Research (3,585)
- Events (3)
- Multimedia (212)
- Faculty Publications (2,763)
Show Results For
- All HBS Web
(6,517)
- People (18)
- News (2,152)
- Research (3,585)
- Events (3)
- Multimedia (212)
- Faculty Publications (2,763)
- 15 Dec 2024
- News
Agenda: Amanda E/J Morrison (MBA 2014)
RIPPLE EFFECT “A woman gets a period around age 12 to 14, and then we tell her to go off in the world and not get pregnant.” “A woman gets a period around age 12 to 14, and then we tell her to go off in the world and not get pregnant.” For 15 years, the morning-after... View Details
- September 17, 2020
- Article
Protecting Vulnerable Older Patients during the Pandemic
By: Umar Ikram, Susanna Gallani, Jose F. Figueroa and Thomas W. Feeley
Older people (70 years and older) with multiple chronic conditions have the highest risk of being hospitalized and dying from COVID-19. The recent COVID-19 pandemic has highlighted how a strong primary care system can play an important role in protecting this group of... View Details
Keywords: COVID-19; High-risk Patients; Primary Care; Health Pandemics; Health Care and Treatment; Innovation and Invention; Demographics; Age
Ikram, Umar, Susanna Gallani, Jose F. Figueroa, and Thomas W. Feeley. "Protecting Vulnerable Older Patients during the Pandemic." NEJM Catalyst (September 17, 2020).
- January 1978
- Case
Zero-Base Budgeting in the Public Health Service
Herzlinger, Regina E. "Zero-Base Budgeting in the Public Health Service." Harvard Business School Case 178-080, January 1978.
- June 2013
- Teaching Note
Boston Children's Hospital: Measuring Patient Costs
By: Robert S. Kaplan
- September 2, 2020
- Article
How to Pay for Public Option Without Tax Hike
By: Regina E. Herzlinger and Richard Boxer
A bipartisan combination of the two parties’ most popular initiatives can expand health care coverage, significantly reduce costs, and enable freedom of choice, without raising taxes. Along the way, we can revitalize competition between public and private plans. Our... View Details
Keywords: Health Insurance; Public Option; Health Care and Treatment; Insurance; Cost Management; United States
Herzlinger, Regina E., and Richard Boxer. "How to Pay for Public Option Without Tax Hike." RealClearPolicy (September 2, 2020).
- March 2014 (Revised December 2014)
- Case
Vision 2020: Takeda and the Vaccine Business
By: John A. Quelch and Margaret L. Rodriguez
In 2014, Yasuchika Hasegawa was orchestrating the transformation of Takeda from a Japanese pharmaceutical company with a global footprint into a global company with a Japanese heritage. A 33-year veteran of Takeda, Hasegawa-san was appointed president of Takeda in 2003... View Details
Keywords: Health Care; Global; NGO; Public Health; Japan; GSK; Vaccine; Supply Chain; Market Entry; Health; Health Care and Treatment; Trade; Market Entry and Exit; Global Strategy; Health Industry; Health Industry
Quelch, John A., and Margaret L. Rodriguez. "Vision 2020: Takeda and the Vaccine Business." Harvard Business School Case 514-084, March 2014. (Revised December 2014.)
- October 2013
- Case
FasterCures: Removing Barriers to Treatments
By: Richard G. Hamermesh and James Weber
In mid-2013, as FasterCures celebrated its 10th anniversary as a center of the Milken Institute, Executive Director Margaret Anderson thought about what the organization should do to ensure it had even more impact in its next 10 years. FasterCures was a non-profit... View Details
Keywords: Health Care; Health Care Industry; Health Care Policy; Health Services; Healthcare; Healthcare Reform; Healthcare Ventures; Nonprofit; Non-profit Management; Not-for-profit; Incubator; Accelerator; Venture Philanthropy; Medical Services; Medical Solutions; Medical Research; Medical Treatment; Clinical Trials; Drug Reimbursement; Early Stage; Early Stage Research Funding; Early Stage Funding; Milken Institute; Michael Milken; David Baltimore; Partnering For Cures; National Institutes Of Health; Cancer Care In The U.S.; Cancer Care Services; Policy-making; Health Care and Treatment; Health; Health Testing and Trials; Entrepreneurship; Social Entrepreneurship; Nonprofit Organizations; Policy; Health Industry; United States; District of Columbia
Hamermesh, Richard G., and James Weber. "FasterCures: Removing Barriers to Treatments." Harvard Business School Case 814-003, October 2013.
- 06 Feb 2007
- News
Universal Health Care: A New Business Paradigm?
- 05 Sep 2013
- News
Who Will Radically Disrupt American Health Care?
- 01 Dec 2011
- News
Research With Impact: Changing Global Health Practices
public policy, and social challenges. In health care, for example, the dominant policy model assumes that access and affordability are the keys to improving care for the poor. In Ashraf’s view, “We can’t... View Details
- October 2020
- Case
Michael Phelps: 'It's Okay to Not Be Okay'
By: Boris Groysberg, Carin-Isabel Knoop and Michael Norris
In 2020, Michael Phelps, the most decorated Olympian of all time, with 28 medals in various swimming events, was now retired. As he looked back on his 20+ year athletic career, he considered what had gone into making him the greatest of all time—the highs and lows,... View Details
Keywords: Mental Health; Talent and Talent Management; Training; Health; Success; Performance Improvement; Personal Development and Career; Family and Family Relationships; Sports; Competition; Sports Industry; United States; Baltimore; Arizona; Sydney; Athens; Beijing; London
Groysberg, Boris, Carin-Isabel Knoop, and Michael Norris. "Michael Phelps: 'It's Okay to Not Be Okay'." Harvard Business School Case 421-044, October 2020.
- August 2007 (Revised January 2008)
- Supplement
Turnaround at the Veterans Health Administration (B)
By: Amy C. Edmondson and Brian R. Golden
Edmondson, Amy C., and Brian R. Golden. "Turnaround at the Veterans Health Administration (B)." Harvard Business School Supplement 608-062, August 2007. (Revised January 2008.)
- December 2011
- Article
Data Impediments to Empirical Work on Health Insurance Markets
By: Leemore S. Dafny, David Dranove, Frank Limbrock and Fiona Scott Morton
We compare four datasets that researchers might use to study competition in the health insurance industry. We show that the two datasets most commonly used to estimate market concentration differ considerably from each other (both in levels and in changes over time),... View Details
Dafny, Leemore S., David Dranove, Frank Limbrock, and Fiona Scott Morton. "Data Impediments to Empirical Work on Health Insurance Markets." B.E. Journal of Economic Analysis & Policy 11, no. 2 (December 2011).
- 2023
- Working Paper
Achieving Universal Health Insurance Coverage in the United States: Addressing Market Failures or Providing a Social Floor?
By: Katherine Baicker, Amitabh Chandra and Mark Shepard
The United States spends substantially more on health care than most developed countries, yet leaves a greater share of the population uninsured. We suggest that incremental insurance expansions focused on addressing market failures will propagate inefficiencies and... View Details
Baicker, Katherine, Amitabh Chandra, and Mark Shepard. "Achieving Universal Health Insurance Coverage in the United States: Addressing Market Failures or Providing a Social Floor?" NBER Working Paper Series, No. 30854, January 2023.
- 14 Jun 2021
- News
Why the Hottest Primary Care Startups Aren't Chasing Medicaid
- September 2014
- Supplement
Pfizer and AstraZeneca: Marketing an Acquisition (B)
By: John A. Quelch and James Weber
This (B) case provides a brief description of the outcome of the (A) case. View Details
Keywords: Health Care Policy; Pharmaceutical Sales; Mergers And Acquisitions; Marketing; Pharmaceutical Industry; United Kingdom; United States
Quelch, John A., and James Weber. "Pfizer and AstraZeneca: Marketing an Acquisition (B)." Harvard Business School Supplement 515-008, September 2014.
- May 1981
- Case
Hospital Affiliates International, Inc. and the Hospital Management Industry
Porter, Michael E. "Hospital Affiliates International, Inc. and the Hospital Management Industry." Harvard Business School Case 381-205, May 1981.
- 29 Jun 2021
- News